1. Home
  2. LQDA vs AUB Comparison

LQDA vs AUB Comparison

Compare LQDA & AUB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

LQDA

Liquidia Corporation

HOLD

Current Price

$78.03

Market Cap

5.5B

Sector

Health Care

ML Signal

HOLD

Logo Atlantic Union Bankshares Corporation

AUB

Atlantic Union Bankshares Corporation

HOLD

Current Price

$41.77

Market Cap

5.1B

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
LQDA
AUB
Founded
2004
1902
Country
United States
United States
Employees
N/A
3064
Industry
Biotechnology: Pharmaceutical Preparations
Major Banks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
5.5B
5.1B
IPO Year
2020
N/A

Fundamental Metrics

Financial Performance
Metric
LQDA
AUB
Price
$78.03
$41.77
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
11
8
Target Price
$41.00
$41.88
AVG Volume (30 Days)
2.4M
1.0M
Earning Date
05-08-2026
04-21-2026
Dividend Yield
N/A
3.98%
EPS Growth
51.81
N/A
EPS
0.52
N/A
Revenue
$158,320,000.00
N/A
Revenue This Year
$278.87
$29.16
Revenue Next Year
$57.13
$4.59
P/E Ratio
$147.92
$19.68
Revenue Growth
1031.18
N/A
52 Week Low
$11.85
$30.39
52 Week High
$78.25
$42.18

Technical Indicators

Market Signals
Indicator
LQDA
AUB
Relative Strength Index (RSI) 75.44 68.73
Support Level $31.23 $36.35
Resistance Level N/A $42.18
Average True Range (ATR) 4.14 0.86
MACD 0.40 0.27
Stochastic Oscillator 91.55 95.29

Price Performance

Historical Comparison
LQDA
AUB

About LQDA Liquidia Corporation

Liquidia Corp is a United States-based biopharmaceutical company focused on the development, manufacturing, and commercialization of products that address unmet patient needs, with the current focus directed towards the treatment of pulmonary hypertension (PH) and pulmonary hypertension associated with interstitial lung disease. It conducts research, development, and manufacturing of novel products by applying its proprietary PRINT technology, a particle engineering platform, to enable the precise production of uniform drug particles. Its product includes YUTREPIA (treprostinil) inhalation powder, for the treatment of pulmonary arterial hypertension. The company also conducting studies on L606, an investigational, liposomal formulation of treprostinil.

About AUB Atlantic Union Bankshares Corporation

Atlantic Union Bankshares Corp is a financial and bank holding company based in the U.S. Through its community bank subsidiary and non-bank financial services affiliates, the company provides financial services, including banking, trust, and wealth management. It offers consumers and businesses a wide range of banking and related financial services, including checking, savings, certificates of deposit, and other depository services, as well as loans for commercial, industrial, residential mortgage, and consumer purposes. The company operates through two reportable operating segments: Wholesale Banking and Consumer Banking, with corporate support functions such as corporate treasury and others included in Corporate Other. It derives maximum revenue from the Wholesale Banking segment.

Share on Social Networks: